Mr Andrew [Muter John] Ogilvie [directeur des transmissions de l'armée anglaise] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57288

Dernier Conseil suprême, 9-1-20, [Hugh Wallace], Lloyd George, Bonar Law [Paris, ministère des Affaires étrangères] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57551

Amiral Sims : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57728

Iowa Community Empowerment Newsletter, June 2002, Vol. 3, no. 3

Monthly newsletter for the Iowa Department of Public Health

ABD e-News October 1, 2004

Weekly newsletter for the State of Iowa Alcoholic Beverages Division

Haben selektive COX-2-Hemmer unerwünschte renale und kardiovaskuläre Wirkungen [Do selective COX-2 inhibitors have adverse renal and cardiovascular effects?].

Selective cyclooxygenase-2-inhibitors (COX-2) were developed as an alternative to the non-steroidal anti-inflammatory drugs (NSAID) in order to reduce their known gastrointestinal and renal toxicity. Several recent studies have shown the complex mechanism of the cyclooxygenase-2. The inhibition of the COX-2 has effects on renal hemodynamics, renal salt and water retention and may increase the thromboembolic and therefore the cardiovascular risk. The renal toxicity of the COX-2 inhibitors is similar to that of traditional NSAID. Regarding these data, COX-2 inhibitors should be prescribed with much caution to high risk patients, that is, patients with renal failure and/or cardiovascular diseases.